These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 19641357)

  • 1. Management outcome of acute urinary retention: model of prediction.
    Daly P; Connolly S; Rogers E; Sweeney P
    Urol Int; 2009; 83(1):39-43. PubMed ID: 19641357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate size influences the outcome after presenting with acute urinary retention.
    McNeill AS; Rizvi S; Byrne DJ
    BJU Int; 2004 Sep; 94(4):559-62. PubMed ID: 15329112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of acute urinary retention in France: a cross-sectional survey in 2618 men with benign prostatic hyperplasia.
    Desgrandchamps F; De La Taille A; Doublet JD;
    BJU Int; 2006 Apr; 97(4):727-33. PubMed ID: 16536763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.
    McNeill SA; Hargreave TB; Roehrborn CG;
    Urology; 2005 Jan; 65(1):83-9; discussion 89-90. PubMed ID: 15667868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alfuzosin 10 mg once daily increases the chances of successful trial without catheter after acute urinary retention secondary to benign prostate hyperplasia.
    Tiong HY; Tibung MJ; Macalalag M; Li MK; Consigliere D
    Urol Int; 2009; 83(1):44-8. PubMed ID: 19641358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
    Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
    Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Reten-World survey of the management of acute urinary retention: preliminary results.
    Emberton M; Fitzpatrick JM
    BJU Int; 2008 Mar; 101 Suppl 3():27-32. PubMed ID: 18307683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of alpha-blockers in the management of acute urinary retention caused by benign prostatic obstruction.
    Alan McNeill S
    Eur Urol; 2004 Mar; 45(3):325-32. PubMed ID: 15036678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia.
    Bhomi KK; Bhattachan CL
    Nepal Med Coll J; 2011 Sep; 13(3):178-81. PubMed ID: 22808810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of treatment with tamsulosin in men with acute urinary retention.
    Kim HL; Kim JC; Benson DA; Bales GT; Gerber GS
    Tech Urol; 2001 Dec; 7(4):256-60. PubMed ID: 11763483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of conservatively managed acute urinary retention: prostate size matters.
    Kumar V; Marr C; Bhuvangiri A; Irwin P
    BJU Int; 2000 Nov; 86(7):816-9. PubMed ID: 11069406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia.
    Prieto L; Romero J; López C; Ortiz M; Pacheco JJ
    Urol Int; 2008; 81(1):66-71. PubMed ID: 18645274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.
    Mabjeesh NJ; Chen J; Stenger A; Matzkin H
    Urology; 2007 Sep; 70(3):548-53. PubMed ID: 17905113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia.
    Fitzpatrick JM; Desgrandchamps F; Adjali K; Gomez Guerra L; Hong SJ; El Khalid S; Ratana-Olarn K;
    BJU Int; 2012 Jan; 109(1):88-95. PubMed ID: 22117624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of PSA in the detection of carcinoma of the prostate in patients presenting with acute urinary retention.
    McNeill SA; Hargreave TB
    J R Coll Surg Edinb; 2000 Aug; 45(4):227-30. PubMed ID: 11130021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of in-and-out catheterization as a way of trial without catheterization strategy for treatment of acute urinary retention induced by benign prostate hyperplasia: variables predicting success outcome.
    Ko YH; Kim JW; Kang SG; Jang HA; Kang SH; Park HS; Moon du G; Cheon J; Kim JJ; Lee JG
    Neurourol Urodyn; 2012 Apr; 31(4):460-4. PubMed ID: 22331691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of successful trial without catheter following acute urinary retention in benign prostatic enlargement: A single centre, multivariate analysis.
    Bansal A; Arora A
    Neurourol Urodyn; 2017 Sep; 36(7):1757-1762. PubMed ID: 28101889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between acute urinary retention, chronic prostatic inflammation and accompanying elevated prostate-specific antigen.
    Kefi A; Koseoglu H; Celebi I; Yorukoglu K; Esen A
    Scand J Urol Nephrol; 2006; 40(2):155-60. PubMed ID: 16608815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign prostatic hyperplasia: mode of presentation and postoperative outcome.
    Khan M; Khan AL; Khan S; Nawaz H
    J Pak Med Assoc; 2005 Jan; 55(1):20-3. PubMed ID: 15816691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of acute urinary retention.
    Fitzpatrick JM; Kirby RS
    BJU Int; 2006 Apr; 97 Suppl 2():16-20; discussion 21-2. PubMed ID: 16507048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.